Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shengji Zhitong Burn Ointment is a topical Traditional Chinese Medicine (TCM) pharmaceutical developed by Guangdong Songde Pharmaceutical Co., Ltd., specifically indicated for the treatment of deep second-degree burns. The formulation is designed to facilitate the 'Shengji' (tissue regeneration) and 'Zhitong' (analgesia) processes, which are critical for the recovery of severe thermal injuries. It works by creating a moist physiological environment at the wound site, which promotes the growth of granulation tissue and accelerates epithelialization. This mechanism helps to shorten wound healing time, reduce local inflammation, and improve the quality of scar formation. The product has been approved by the National Medical Products Administration (NMPA) in China following clinical evaluations, including Phase III trials, that demonstrated its efficacy and safety in managing deep-tissue burns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shengji zhitong burn ointment.